Therapeutic Solutions International Successfully Treats Veteran Navy SEAL Suffering from Chronic Traumatic Encephalopathy with JadiCell™ Adult Stem Cells Under Right to Try Law
Therapeutic Solutions International (TSOI) announced successful treatment of a Navy SEAL Veteran suffering from Chronic Traumatic Encephalopathy (CTE) using JadiCell adult stem cells.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Therapeutic Solutions International (TSOI) announced successful treatment of a Navy SEAL Veteran suffering from Chronic Traumatic Encephalopathy (CTE) using JadiCell adult stem cells. The treatment involved two injections with no adverse events reported. The company is committed to clinical trials, having received Phase III clearance for COVID-19 ARDS and planning a Phase I/II trial for CTE. The initiative provides pro bono access to military personnel. The CEO expressed pride in supporting veterans amid rising suicide rates, emphasizing the urgent need for new therapeutic strategies.
Positive
- Successful treatment of a Navy SEAL Veteran with JadiCell stem cells.
- No adverse events reported from the treatment.
- Initiatives to provide treatments pro bono to military personnel.
- Phase III clearance received for COVID-19 ARDS trials.
- Plans to launch Phase I/II trial for CTE.
Negative
- None.
Details
News Market Reaction – TSOI
The recorded move for TSOI in the trading session of this news was -3.61%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ELK CITY, Idaho, Sept. 13, 2021 /PRNewswire/ -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today successful treatment of a United States Navy SEAL Veteran suffering from Chronic Traumatic Encephalopathy (CTE). The patient received 2 injections of the JadiCell adult stem cells, no treatment associated adverse events were noted.
The cells were provided under a newly initiated program under which Therapeutic Solutions International provides access to its technologies Pro Bono, to members of the Armed Forces who have defended the United States.
"We are
CTE is caused by repeated injuries to the brain causing chronic inflammation, deterioration of neuronal communication, and death of brain cells. These culminate in various symptomologies including depression, violence, and suicidality.
"My father was a combat veteran Marine of WWII and Korea; I fully understand the extreme sacrifices made by members of our Armed Forces in the defense of our Freedom, our Nation, and our National Security," said Timothy Dixon, President and CEO of the Company. "We are a Company that is proud of being in a position to give something back to the bravest segment of our society."
About Therapeutic Solutions International, Inc.
Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com, and our public forum is https://board.therapeuticsolutionsint.com/
View original content:SOURCE Therapeutic Solutions International
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.